We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Panel of 18 Biochemical Tests Rapidly Identifies Staphylococcus

By Labmedica staff writers
Posted on 18 Feb 2008
A panel of 18 tests has been launched for the biochemical identification of Staphylococcus species and related organisms isolated from human clinical specimens.

Called Remel RapID Staph Plus, the rapid manual identification system offers clinical laboratories of any size a valuable new diagnostic tool for an important group of opportunistic pathogens. More...
All of the test wells are inoculated simultaneously and the panel is then incubated aerobically for four hours.

Resultant color reactions are easy to read and are used to identify the organism using the RapID Staph Plus color guide, which helps generate a numeric microcode. The microcode is entered into Windows-based software for organism identification. This user-friendly package contains a comprehensive database of 40 medically important Staphylococcus species and related organisms, and ranks identifications by probability (greater than 95% probability is required for species level identification), ensuring accuracy and reliability.

The RapID Staph Plus can identify Staphylococcus aureus and over 30 species of coagulase negative staphylococci (CNS) in addition to other related organisms. CNS are an increasingly important cause of nosocomial infections. They are the most common causal agents of bacteraemia in patients with indwelling medical devices and are one of the most common causes of septicemia in pediatric patients.

RapID Staph Plus was developed by Oxoid (Basingstoke, UK

Julie Elston, clinical products application manager at Oxoid, commented, "The serious nature of bacteraemia means that there is little time to spare in determining the best course of action. Long delays simply are [not] acceptable and, as a result, the empiric use of agents such as vancomycin is common. RapID Staph Plus gives rapid, same-day results, allowing appropriate therapy to be determined more quickly and providing an opportunity for the use of vancomycin to be restricted to only when it is absolutely necessary.”

Oxoid's RapID range includes products for the identification of oxidase-negative Enterobacteriaceae, anaerobic bacteria, Gram-negative glucose non-fermenters, Corynebacterium species, Neisseria and Haemophilus (common in urinary infections), yeasts and related organisms, and Streptococci and related organisms.


Related Links:
Oxoid

Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Shaking Incubator
Corning LSE 71L
New
Giardia Assay
AccuDiag Giardia
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Gut microbes may help in recognizing and treating pancreatic cancer (Photo courtesy of Adobe Stock)

Gut Microbes Could Enable Early Detection and Treatment of Pancreatic Cancer

Pancreatic cancer remains one of the most serious and challenging diseases in oncology due to its difficulty in detection and limited treatment options. Now, a new international collaborative study suggests... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Industry

view channel
Image: The knowledge transfer partnership will further develop technology to rapidly diagnose serious and high-risk infectious diseases (Photo courtesy of Aston University)

Aston University and BG Research Partner to Commercialize Groundbreaking Medical Diagnostic

Technology that can rapidly diagnose high-consequence infectious diseases will take a major step forward towards commercialization, thanks to a new partnership. A Knowledge Transfer Partnership (KTP)... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.